Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer

Abstract Background Early detection of treatment failure may improve clinical outcome and overall survival in patients with head and neck cancer after first-line treatment. Circulating cell-free HPV16 DNA (cfHPV16 DNA) was evaluated as a possible complementary marker to radiological assessment of ea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tomasz W. Rutkowski, Agnieszka M. Mazurek, Mirosław Śnietura, Beata Hejduk, Maja Jędrzejewska, Barbara Bobek-Billewicz, Andrea d’Amico, Wojciech Pigłowski, Andrzej Wygoda, Krzysztof Składowski, Zofia Kołosza, Piotr Widłak
Format: Artigo
Idioma:Inglês
Publicat: BMC 2020-04-01
Col·lecció:Journal of Translational Medicine
Matèries:
Oropharyngeal cancer
HPV
Radiotherapy
Follow-up
Treatment failure
Salvage
Accés en línia:http://link.springer.com/article/10.1186/s12967-020-02330-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars